Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00279500 · ClinicalTrials.gov registry record · NA
Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa
A NA study, sponsored by Second Sight Medical Products.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT00279500 is a NA study that has completed, run by Second Sight Medical Products. The registered enrollment target is 6 participants.
The verdict
NCT00279500, a NA study, has completed, sponsored by Second Sight Medical Products.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and efficacy of the retinal stimulation system by evaluating the data after chronic implantation.
Interventions
- DEVICE Argus 16 Retinal Stimulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2002-02-27 |
| Est. Completion | 2014-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00279500
The ClinicalTrials.gov registry entry for NCT00279500 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Second Sight Medical Products, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Argus 16 Retinal Stimulation System is the first listed.
NCT00279500 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00279500 about?
NCT00279500 is a clinical study titled "Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa". The objective of this study is to evaluate the safety and efficacy of the retinal stimulation system by evaluating the data after chronic implantation.
What is the current status of trial NCT00279500?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2002-02-27. Estimated completion is 2014-12-31.
What interventions are being tested in trial NCT00279500?
The interventions under investigation include: Argus 16 Retinal Stimulation System (DEVICE).
Who is sponsoring clinical trial NCT00279500?
This trial is sponsored by Second Sight Medical Products, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.